Abstract Background Chloroquine (CQ), amodiaquine (AQ), and sulfadoxine‐pyrimethamine
(SP) are inexpensive drugs, but treatment failure is a problem. Combination therapy may …

Background Using a pilot system we have categorised this review as: Historical question‐no
update intended. Please see" Published notes" section of the review for more details. Since …

Objective To compare the efficacies against uncomplicated falciparum malaria of
chloroquine (CQ), amodiaquine (AQ), sulfadoxine–pyrimethamine (SP) and combinations of …

The 4-aminoquinolines, chloroquine or amodiaquine, have long been the drugs of choice for
treating uncomplicated, falciparum malaria in Africa, although resistance to them is now …

Chlorproguanil‐dapsone for treating uncomplicated malaria - Bukirwa, H - 2004 | Cochrane
Library Skip to Content Cookies Our site uses cookies to improve your experience. You can …

Artesunate plus mefloquine versus mefloquine for treating uncomplicated malaria - Bukirwa,
H - 2005 | Cochrane Library Skip to Content Cookies Our site uses cookies to improve your …

Background Artemisinin‐based combination treatments are strongly advocated, but supplies
are limited. Sulfadoxine combined with amodiaquine is an alternative non‐artemisinin …

Drug resistance in Plasmodium falciparum is a major obstacle to malaria control. Artemisinin-
based combination therapy (ACT) is being advocated to improve treatment efficacy and to …

Background Despite the expectations regarding the effectiveness of chloroquine (CQ) and
hydroxychloroquine (HCQ) for coronavirus disease (COVID-19) management, concerns …

Background The predominance of chloroquine-susceptible falciparum malaria in Malawi
more than a decade after chloroquine's withdrawal permits contemplation of re-introducing …